The Food and Drug Administration has approved the use of ESWT for the treatment of plantar fasciopathy. However, Dr. Finnoff notes that multiple high-quality randomized clinical trials have provided substantial evidence that ESWT is a safe and effective noninvasive option for treating tendinopathy throughout the musculoskeletal system. 

• Rotator cuff
• Lateral epicondyle
• Medial epicondyle
• Greater trochanter (gluteus medius and minimus)
• Proximal hamstring origin
• Rectus femoris
• Distal quadricep
• Patellar tendon
• Posterior tibial
• Peroneal
• Achilles
• Plantar fascia
•